scispace - formally typeset
A

Anette Duensing

Researcher at University of Pittsburgh

Publications -  71
Citations -  5945

Anette Duensing is an academic researcher from University of Pittsburgh. The author has contributed to research in topics: Imatinib mesylate & Centrosome. The author has an hindex of 30, co-authored 69 publications receiving 5519 citations. Previous affiliations of Anette Duensing include Brigham and Women's Hospital.

Papers
More filters
Journal ArticleDOI

p21(Waf1/Cip1) deficiency stimulates centriole overduplication.

TL;DR: It is shown that knock-down of p21 protein expression in murine myeloblasts can stimulate excessive centriole numbers in the presence of only one or two mature centrioles, and that aberrant centrosome numbers cannot solely be explained by polyploidization as suggested by previous studies.
Journal ArticleDOI

Mutations in BRCA2 and taxane resistance in prostate cancer

TL;DR: There is overall a significant correlation between BRCA2 inactivation and a poor response rate to docetaxel, and the results suggest that a close oncological monitoring of patients with BRCa2 mutations for taxane resistance is warranted.
Journal ArticleDOI

A novel role of the aryl hydrocarbon receptor (AhR) in centrosome amplification - implications for chemoprevention

TL;DR: Indirubin-derived compounds that have been chemically modified to be inactive as kinase inhibitors still significantly reduced centrosome amplification, suggesting that these compounds are potentially useful for the chemoprevention of centrerosome-mediated cell division errors and malignant progression in neoplasms in which the AhR is overexpressed.
Journal ArticleDOI

Synergistic induction of apoptosis by the Bcl-2 inhibitor ABT-737 and imatinib mesylate in gastrointestinal stromal tumor cells

TL;DR: The antitumor effects of the pro‐apoptotic Bcl‐2/Bcl‐xL inhibitor ABT‐737 are examined alone and in combination with imatinib to enhance imatin ib‐induced cytotoxicity and overcome imatinIB‐resistance in GIST cells.